Ketin

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ketin

Property Description
Active ingredient Ketoprofen
Form Tablet, Capsule, Gel, Injection
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common purpose Pain relief, inflammation reduction, fever reduction
Origin Synthetic compound (Propionic acid derivative)

What Type of Medicine is Ketin (Ketoprofen)?

Ketin is a pharmaceutical preparation whose core active component is Ketoprofen, a substance recognized as an Essential Medicine. It is scientifically classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). Ketoprofen is a synthetic compound derived from Propionic acid, defining it as a non-narcotic peripheral analgesic that targets the mechanisms of pain and inflammation at the tissue level. Ketoprofen has an established use in general pain management. This medication is used to provide relief from discomfort.


Ketin's Composition and Available Forms

Ketoprofen is a single active ingredient product formulated into a variety of pharmaceutical preparations to ensure flexibility in delivery. For systemic treatment, which requires the drug to circulate throughout the body, Ketoprofen is available in forms such as Tablets, Capsules, Suppositories, and Solutions for injection, allowing for Oral, Rectal, and Parenteral routes of administration. For localized effects, or topical treatment, it is prepared as Gels, Creams, and Topical patches, where the active ingredient is combined with an appropriate base/vehicle. Topical formulations are designed to deliver the drug locally. This supports the use of these preparations for targeted relief, such as in instances of muscle strain.


What is the General Purpose of Ketin?

The general purpose of Ketin stems directly from its NSAID function, which involves the inhibition of Cyclooxygenase (COX) enzymes. This action reduces the biological synthesis of prostaglandins, the chemical mediators responsible for signaling pain, initiating inflammatory swelling, and causing fever. Therefore, the medication provides a combined benefit: it helps relieve pain, reduce inflammation (alleviating symptoms like swelling and heat), and lower fever, offering symptomatic control across various conditions.

Regulatory References

  1. WHO Essential Medicines Lists

What side effects are possible with Ketin?

Possible Side Effects and Safety Information

The safety profile of Ketin is formally documented by regulatory authorities, with adverse reactions categorized by the body system affected and their reported frequency.

Frequency-Classified Adverse Reactions

Side effects observed in clinical trials and post-marketing surveillance are grouped by how often they occur:

  • Very Common / Common: Elevated blood pressure, increased heart rate, and central nervous system effects known as "emergence reactions." These may involve vivid dreams, confusion, or hallucinations during recovery. Other common effects include nausea and vomiting.
  • Uncommon / Rare: Severe respiratory depression or apnea (cessation of breathing), hypotension (low blood pressure), cardiac arrhythmia, and laryngospasm (spasm of the vocal cords). Serious hypersensitivity reactions, including anaphylaxis, have been reported.

Serious Adverse Reactions and System-Organ Classes

The most clinically significant adverse reactions involve the Cardiovascular System (marked by hemodynamic instability), the Respiratory System (risk of severe respiratory depression), and the Nervous System (emergence phenomena, increased intracranial pressure, and the potential for dependence). Drug-induced liver injury is also a documented serious risk.

Safety-Related Restrictions and Considerations

  • Contraindications: Ketin is formally restricted for use in patients with known hypersensitivity to the medicine or its excipients. It is also contraindicated in patients for whom a significant elevation of blood pressure would constitute a serious medical hazard.
  • Population-Specific Warnings: Repeated or prolonged use in children younger than three years may potentially result in negative effects on the developing brain, based on animal data. Caution is advised for use in elderly patients and those with underlying severe cardiac disease, uncontrolled hypertension, or conditions involving elevated cerebrospinal fluid pressure.
  • Monitoring Notes: Continuous monitoring of vital signs and cardiac function is explicitly required during administration due to the risk of hemodynamic instability. Airway management equipment must be readily available because of the risk of respiratory depression.

Overdose and Emergency Response

Overdose and When to Seek Help

Ketin (ketamine) overdose is a medical emergency that requires immediate attention. Overdose is more likely to occur with high-dose use, rapid administration, or when the drug is combined with central nervous system depressants like alcohol, sedatives, or opioids, which significantly increases the risk of respiratory depression.

Documented Overdose Symptoms

The signs and symptoms of acute Ketin overdose or toxicity are primarily characterized by severe effects on the central nervous system, cardiovascular system, and respiratory function. These may include:

  • Profound sedation or marked decrease in consciousness, potentially leading to stupor or coma.
  • Respiratory distress, including dangerously slowed breathing (respiratory depression) or periods of stopped breathing (apnea).
  • Cardiovascular changes such as very high blood pressure (hypertension), rapid or irregular heartbeat (tachycardia), or, conversely, low blood pressure (hypotension) and slow heart rate (bradycardia).
  • Neurological manifestations like severe confusion, disorientation, agitation, seizures, and vivid, unpleasant hallucinations.

Required Emergency Action

Call for emergency medical help immediately if an overdose is suspected, even if symptoms appear mild or you are unsure of the dose taken. There is no specific antidote to reverse the effects of Ketin. Treatment for overdose is symptomatic and supportive care, which often includes monitoring vital signs, securing the airway, providing respiratory support (such as assisted ventilation or supplemental oxygen), and using medications to manage symptoms like agitation or seizures in a supervised medical setting.

Immediate medical evaluation is critical due to the potential for life-threatening complications, especially respiratory arrest and cardiac events.

Therapeutic Uses of Ketin

What Ketin Treats: Main Uses and Benefits

Ketin (Ketoprofen) is commonly used to help manage symptoms related to physical discomfort and systemic imbalance, applying its dual symptomatic benefits across a range of clinical presentations. This approach is relevant across domains where additional symptomatic support is needed.

The medication is relevant when short-term symptomatic assistance is needed, often used for conditions presenting with acute or fluctuating symptom patterns, including the discomfort of Osteoarthritis, Rheumatoid Arthritis, Tendinitis, Gout, and pain following trauma or surgical procedures. It also helps address the pronounced symptoms of cramping pain associated with Primary Dysmenorrhea and systemic discomfort like fever.

Ketin provides support that helps ease the overall symptom burden, particularly during flare-ups or periods of heightened symptoms.

“It is applied in clinical settings that involve acute or unstable symptom patterns, supporting the patient during difficult episodes by helping patients cope more steadily.”


Quick Fact: Relief for Inflammation and Pain

Ketin is relevant for easing symptoms that create noticeable functional strain, such as localized swelling, stiffness, and tenderness.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Contraindications and Prohibited Use

Ketin (Ketoprofen) is contraindicated and must not be used by patients with a documented hypersensitivity to Ketoprofen, aspirin, or any other Nonsteroidal Anti-inflammatory Drug (NSAID). Absolute prohibitions also apply to patients with active peptic ulcers, severe cardiac insufficiency, or those receiving treatment for pain following Coronary Artery Bypass Graft (CABG) surgery. Use is strictly prohibited for women who are pregnant at or after 30 weeks gestation (third trimester).


Age and Condition-Based Restrictions

Regulatory documents place specific limitations on several populations. Safety and effectiveness have not been established for the pediatric population (under 18 years), rendering use not recommended. Older adults require special caution due to an increased risk of serious adverse effects. Conditional use applies to patients with severe renal or hepatic impairment, necessitating close supervision. Use during the first two trimesters of pregnancy is restricted, and the medicine is not recommended for use while breastfeeding, as safety in nursing infants has not been determined.

What should I know about interactions with other medicines?

Interaction scope

Medicinal product categories with documented interactions:

  • Other Nonsteroidal Anti-inflammatory Drugs (NSAIDs) (including aspirin)
  • Anticoagulants (e.g., Warfarin)
  • Antiplatelet Agents, SSRIs, and Oral Corticosteroids
  • ACE-Inhibitors, ARBs, and Diuretics
  • Lithium, Methotrexate, and Probenecid

Specific interacting medicines (if explicitly listed): Aspirin, Warfarin, Lithium, Methotrexate, Probenecid.

Mechanistic basis of interactions (only if stated in label): Pharmacodynamic interaction resulting in synergistic increase of bleeding risk; reduction of antihypertensive or natriuretic effect; Pharmacokinetic interaction where Probenecid reduces plasma clearance of Ketin, increasing its systemic exposure [Source: DailyMed]. Ketin does not induce drug-metabolizing enzymes [Source: FDA Label].

Timing-based interaction rules (if applicable): Co-administration with food for oral forms slows the rate of absorption ( T max is delayed) [Source: FDA Label].

Population-specific interaction notes (if applicable): Elderly patients face a greater risk of serious gastrointestinal adverse events from interactions [Source: FDA Label]. Patients with impaired renal function face increased risk of renal failure when taking Ketin with diuretics or ACE-inhibitors [Source: DailyMed].

Interaction-related restrictions: Ketin is contraindicated for use in the peri-operative setting of Coronary Artery Bypass Graft (CABG) Surgery [Source: FDA Label]. Concurrent use with Alcohol increases the risk of GI bleeding [Source: DailyMed].


Interaction classifications (high-level)

Interaction severity classification (as defined in official documents):

  • Contraindicated Combination: Condition-specific (CABG).
  • Not Recommended Combinations: Other NSAIDs/Aspirin, Probenecid.
  • Clinically Significant Interactions: Anticoagulants, Lithium, Methotrexate (requiring monitoring).

Regulatory basis (EMA / FDA / etc.): Official interaction statements are consistent with regulatory findings published by the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) / DailyMed.

Interaction-context constraints (as defined in official documents): The official label requires assessment of concurrent use with medicines that alter coagulation, blood pressure, or renal clearance [Source: Regulatory labels].


Resulting interaction structure

Official interaction statements:

  • Co-administration with Anticoagulants is associated with an increased, synergistic risk of hemorrhage [Source: FDA Label].
  • Ketin may officially diminish the antihypertensive effect of ACE-inhibitors and ARBs, and reduce the natriuretic effect of Diuretics [Source: DailyMed].
  • Concurrent use with Lithium causes an elevation of plasma lithium levels due to reduced renal clearance, requiring exposure monitoring [Source: NIH/DailyMed].
  • The co-administration of Probenecid is not recommended because it substantially reduces the plasma clearance of Ketin, increasing systemic exposure [Source: NIH/DailyMed].

Connection to the overall interaction profile (2–4 sentences): Regulatory documents define the product’s interaction structure through established pharmacodynamic and pharmacokinetic patterns, particularly noting additive risks for bleeding and compromised effects on renal hemodynamics. The profile specifies official restrictions on combination use due to synergy with other NSAIDs and mandates procedural monitoring for substances where renal clearance is substantially altered. This structure informs constraints on co-administration.

Mechanism of Action

The mechanism of Ketoprofen, the active component of Ketin, is defined by its action as a non-selective enzyme inhibitor targeting the Cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. This molecular action initiates a cascade that alters activity in several physiological pathways.

The drug acts within the Arachidonic Acid Cascade by reversibly blocking the active sites of COX-1 and COX-2, thereby halting the synthesis of prostaglandins (e.g., PGE2 and PGI2) and other inflammatory mediators. This engagement with the enzyme system reduces the overall production of these chemical mediators.

Reducing the local concentration of prostaglandins translates to a decrease in the chemical sensitization of peripheral nociceptors (pain-sensing nerve endings) at the site of tissue changes. This action restricts the physiological influence of high mediator activity, resulting in a functional alteration of the nociceptive signaling pathway, and consequently decreasing the rate of afferent signal transmission from peripheral nociceptors.

Furthermore, the mechanism extends to the brain's hypothalamus, where PGE2 acts to raise the body's thermostatic set-point during fever. By suppressing PGE2 synthesis in this central region, the drug leads to the normalization of the hypothalamic set-point, resulting in the downward physiological adjustment of core body temperature.

Dosage and Administration Information

How to Use Ketin

The following details the administration routes, dosage rules, and procedural requirements for Ketin (Ketoprofen).


Administration Scope

The medication is administered via Oral and Topical (Cutaneous) routes, corresponding to immediate-release (IR) capsules, extended-release (ER) capsules, and topical gel formulations. The choice of form dictates the dosing pattern and frequency.

Dosage and Frequency

Usage Pattern Dosing Schedule Frequency Maximum Daily Dose
Oral (IR) 25 mg to 75 mg per administration 3 to 4 times daily, or as needed every 6-8 hours 300 mg
Oral (ER) 200 mg Once daily 200 mg
Topical Gel 2 to 4 grams per application 2 to 4 times daily 15 g

Procedural and Contextual Instructions

Oral capsules may be taken with food, milk, or an antacid to help mitigate potential stomach discomfort; this does not significantly alter the overall systemic absorption of the drug. The extended-release capsule must be swallowed whole and is not to be crushed, chewed, or broken apart to ensure the proper release profile.

Topical gel must be applied by gentle and prolonged massage into the affected area. Topical use is intended for the shortest duration necessary for the required use, often limited to a course of seven days. In cases of renal or hepatic impairment, the maximum oral daily dose is restricted to 100 mg to 150 mg.

Recent Clinical Evidence

Research evidence / Overview of studies for Ketin (Ketoprofen)


Evidence for Symptom Management in Chronic Joint Conditions

Randomized Controlled Trials (RCTs) and scientific meta-analyses have studied Ketoprofen in the context of chronic joint issues like Osteoarthritis (OA) and Rheumatoid Arthritis (RA). These studies were used in research exploring how symptoms change over time in patients experiencing conditions characterized by functional limitations. The research examined outcomes related to physical discomfort, such as patient-reported pain intensity scores, and outcomes reflecting daily functioning or activity level, including joint mobility. Study populations included adults and older adults with diagnosed conditions.

The findings from these structured trials, as reported in scientific reviews, generally describe patterns observed in the studies. Research describes measurements tracked during the study period for both pain and joint stiffness. For OA, research has explored both oral and topical formulations. Some trials examining the topical gel recorded measurements in populations observed against the inactive vehicle (the non-drug base).

What remains uncertain is the information for long-term outcomes, as follow-up durations were limited in most key trials. There is limited information for long-term outcomes regarding joint structure or overall disease modification, as studies monitored only symptomatic changes. Data for certain groups, such as patients taking multiple complex medications for comorbidities, may remain insufficient.


Research on Acute Pain and Inflammation

Ketoprofen was evaluated in research exploring acute symptoms in several conditions, including post-operative pain, pain following trauma (like sprains and strains), primary dysmenorrhea (menstrual cramps), and acute episodes of gouty arthritis. These studies primarily involve short-term RCTs and systematic reviews relevant in trials assessing short-term or episodic symptom patterns. Research examined outcomes capturing phases of heightened symptom activity, such as immediate pain scores, measurements of cramping pain, and the tracking of rescue pain medication after surgery.

Findings describe patterns observed in the studies indicating the measurements of pain relief were recorded in groups observed alongside other standard non-opioid pain relievers during the acute phase. For post-operative pain, studies monitored physiological strain or stress, and findings described patterns related to the consumption of other, opioid-based pain relievers in the observed populations. For painful episodic conditions like primary dysmenorrhea and acute gout, studies monitored responses over defined time intervals, with outcomes reflecting daily functioning or activity level during the acute episode.


Long-Term Studies and Follow-Up Data

When considering periods of observation beyond a few months, studies explored the question of extended response and long-term follow-up. The majority of the structured evidence base, particularly the core RCTs, focuses on short-term or intermediate outcomes, such as changes over 3 to 12 weeks. Research describes that the study results reflect the specific conditions under which they were conducted, and typically do not span years.

Long-term outcomes are not fully established for many uses, as evidence is limited regarding symptomatic outcomes or changes in function after the initial research follow-up ends. Research does not determine whether an individual will maintain their response over very long periods. The research base does not include studies specifically evaluating changes to the underlying long-term condition.


Evidence in Special Populations

Research has been conducted in specific groups, including both older adults and, in some contexts, children and adolescents. Older adults were included in research examining patient-reported experiences for chronic conditions like Osteoarthritis. These studies help show what has been observed so far in this age group, though the results apply only to the populations studied and do not provide comprehensive data for the frailest patients or those with severe comorbidities.

For children and adolescents, studies have explored responses for specific acute needs, such as post-operative pain and, in older adolescents, acute traumatic pain. Findings describe group patterns related to these specific, short-term research scenarios. Research provides context but not individual predictions, and data for certain groups (e.g., very young children) remains insufficient.


What is Still Uncertain About Ketin Research

Despite the broad evidence landscape, certain certainty remains low. Research highlights what is known—and what is still uncertain—about this medicine. Data for certain groups remain insufficient, especially for patients with specific, complex pre-existing health conditions or those using the medicine over many years.

Findings indicate that evidence quality varies across studies, particularly between short-term pain trials and those examining long-term maintenance of function. Comparative evidence is lacking for specific head-to-head outcomes against all possible non-NSAID treatments in every indication. The follow-up durations were limited in most key efficacy trials, meaning that long-term outcomes are not fully established, and further study is needed to broaden the understanding of its clinical characteristics.

Key Studies & References

  1. PRODUCT MONOGRAPH KETOPROFEN (Regulatory document detailing indications and clinical pharmacology summary)

Frequently Asked Questions (FAQ)

Common questions about Ketin (FAQ)


Q: Is Ketin considered safe for long-term use?

Studies and official information indicate that the majority of research focuses on short-term or intermediate outcomes. Therefore, evidence for long-term outcomes, such as maintaining symptomatic relief or functional status over many years, is not fully established by the key efficacy trials.


Q: How quickly should I expect Ketin to start working?

Regulatory documents describe that the immediate-release capsule formulation of Ketin is associated with an onset of relief in some patients within approximately 30 minutes of administration.


Q: Does Ketin interact with common over-the-counter pain relievers?

The official interaction profile already warns against using Ketin with other nonsteroidal anti-inflammatory drugs (NSAIDs) to avoid additive risk. However, co-administration with Acetaminophen is not identified in regulatory documents as a clinically significant interaction.


Q: What happens if I stop taking Ketin suddenly?

The safety profile describes findings of potential for dependence related to its effect on the nervous system. The documentation also lists certain central nervous system effects, known as 'emergence reactions,' as serious adverse reactions that have been reported following use or discontinuation.


Q: What are the less common but serious side effects of Ketin?

Less common but serious side effects documented in the official safety information include severe respiratory depression (cessation of breathing), cardiac arrhythmia (irregular heartbeat), hypotension (low blood pressure), and serious hypersensitivity reactions such as anaphylaxis.


Q: Does Ketin affect sleep patterns?

Official safety information lists that potential adverse effects can include drowsiness. Patients have also reported difficulty falling asleep or staying asleep (insomnia).


Q: Is Ketin safe to use during pregnancy, according to official information?

Regulatory information states that Ketin use is strictly prohibited at or after 30 weeks gestation, which is the third trimester. Use during the first two trimesters is restricted, and regulatory documents describe that use during this time requires consideration of the potential benefit versus the potential risk to the fetus.


Q: Is there a generic version of Ketin available?

Yes, the active pharmaceutical ingredient, ketoprofen, is available in a lower-cost generic form.


Q: What is the difference between Ketin and [similar drug]?

Ketin (ketoprofen) is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID) and is a propionic acid derivative. This chemical designation defines it as a distinct medication compared to other drugs within the NSAID class.


Q: Can Ketin be used by people with a history of [common condition]?

Regulatory warnings state that Ketin should be used with special caution in patients who have a history of certain conditions. These include asthma, heart failure, kidney disease, liver disease, and a history of stomach or bowel ulcers or bleeding.


Q: If I miss a dose, what am I supposed to do?

If a regular dose is missed, official information advises taking it as soon as it is remembered. However, if it is almost time for your next scheduled dose, the missed dose should be skipped entirely to avoid accidentally taking a double amount.


Q: Does Ketin affect my ability to drive or operate machinery?

The medication’s safety profile includes potential side effects such as dizziness and drowsiness. Because of these possibilities, these effects may be a factor that influences a person's ability to safely operate machinery or drive.


Q: Is Ketin a controlled substance?

Regulatory agencies do not classify Ketin (ketoprofen) as a controlled substance.


Q: Is it possible to develop a dependency on Ketin?

The official serious adverse reaction warnings include descriptive findings regarding dependence related to its effect on the Nervous System. This information is available in the regulatory documentation.


Q: What should I do if a side effect seems mild?

For mild side effects that persist or worsen over time, official product information advises to tell a doctor or pharmacist promptly. For certain reactions, such as a localized skin rash from topical use, the label advises to discontinue use and consult a healthcare professional.


Q: How long does Ketin stay in my system?

The time it remains active in the body is characterized by a rapid elimination. The average elimination half-life, which measures how quickly the drug is cleared, typically ranges from two to four hours.


Q: Is Ketin suitable for older adults?

Regulatory documents state that older adults require special caution when using this medicine. This is because this population is at a greater risk for serious adverse effects, particularly gastrointestinal bleeding.


Q: Why is Ketin prescribed for [less common use/symptom]?

In addition to main arthritis indications, regulatory information lists its use for managing pain from conditions such as primary dysmenorrhoea (menstrual pain) and acute episodes of gouty arthritis.


Q: What if I have an allergic reaction to Ketin?

If signs of a serious allergic reaction occur, such as swelling of the face or throat, difficulty breathing, or severe hives, regulatory documents instruct that immediate medical attention is necessary.


Q: Is Ketin known to cause weight gain or loss?

Official safety information lists both weight gain (which is often related to fluid retention or edema) and weight loss (often due to loss of appetite) as possible adverse effects.


Q: Can Ketin be given to children?

Safety and effectiveness have not been established for the pediatric population (those under 18 years of age). Due to this lack of established data, the use of this medicine is not recommended in this age group.


Q: What patient populations are excluded from using Ketin in the official labeling?

Official labeling identifies several populations that are strictly excluded from using Ketin. These include patients with a documented hypersensitivity to NSAIDs, those with active peptic ulcers, severe cardiac insufficiency, patients recovering from Coronary Artery Bypass Graft (CABG) surgery, and and women at or after 30 weeks of pregnancy.


Q: Does taking Ketin require any special monitoring or lab tests?

Continuous monitoring of vital signs and cardiac function is explicitly required during initial administration. Furthermore, regulatory documents mandate specific laboratory monitoring when Ketin is co-administered with certain other drugs, such as Lithium or Warfarin.


Q: Is Ketin approved in countries outside of the U.S.?

Yes, the active ingredient, ketoprofen, has been authorized for use and available in many countries outside of the U.S., including European Union Member States, where it has been available since the late 1970s.


Q: Why do some people find Ketin doesn't work for them?

Official information notes that the medication may not work as effectively if it is taken after pain has already worsened significantly. Non-response to treatment is an event that may warrant evaluation by a healthcare professional.


Q: Does Ketin have a risk of causing stomach upset?

Yes, official safety information states that common adverse events are primarily gastrointestinal. These frequently reported effects include upset stomach, abdominal pain, nausea, vomiting, and dyspepsia (indigestion).


Q: Does Ketin interact with birth control pills?

The official drug interaction section does not list hormonal birth control pills as an agent with a known, clinically significant interaction that requires special warnings or monitoring.


Q: Are there any known drug-drug interactions that are considered major?

Yes, regulatory documents define interactions that are classified as contraindicated (such as use near CABG surgery) or not recommended (such as using it with other NSAIDs/Aspirin or Probenecid) due to high safety risks.


Q: Is Ketin known to cause headaches?

Yes, headache is listed in the official safety information as a possible side effect that has been reported by patients.


Q: Is it required to take Ketin at the exact same time every day?

While certain extended-release forms are intended for a regular schedule (such as once daily), the dosing frequency for immediate-release capsules is often listed in a range, suggesting the exact same time daily is less critical than adhering to the required interval.


Q: Can Ketin cause changes in mood or behavior?

Yes, official safety information lists mental/mood changes, confusion, and hallucinations as possible adverse reactions. These effects are classified under the Nervous System disorders.


Q: Does the efficacy of Ketin change over time?

Research results show that studies did not determine whether an individual will maintain their response over very long periods. This is because the follow-up durations in key trials were limited.


Q: Is it true that Ketin is only for severe cases?

The medication is approved for managing a range of symptoms and conditions. This includes relief for mild-to-moderate pain and menstrual pain, not solely severe cases.

How should Ketin be stored and disposed of?

How to Store and Dispose of Ketin (Ketoprofen)

Official regulatory guidelines mandate specific storage and disposal requirements for Ketin to ensure product stability and safety.


Storage and Handling

  • Temperature: Oral forms must be stored at Controlled Room Temperature (20 C to 25 C). Topical gels often require storage below 25 C or 30 C.
  • Environmental Protection: The medicine must be kept in a tightly closed container and protected from freezing, heat, direct light, and moisture.
  • Stability: Some topical gels have a 1-month stability limit after first opening. All medicine must be stored out of the reach of children.

Disposal Requirements

  • Disposal Rule: Do not dispose of unused or expired Ketin by throwing it into household waste or flushing it down a toilet or drain.
  • Protocol: Patients must consult a healthcare professional or pharmacist for instructions on proper disposal, which typically involves returning the product to a collection point, in accordance with local environmental regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ketin found in:

A-Z Index: